<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">32463347</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1744-5078</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>29</Volume>
            <Issue>7-8</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Nov</Month>
              <Day>17</Day>
            </PubDate>
          </JournalIssue>
          <Title>Ocular immunology and inflammation</Title>
          <ISOAbbreviation>Ocul Immunol Inflamm</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Cataract Surgery in the Setting of Scleritis.</ArticleTitle>
        <Pagination>
          <StartPage>1540</StartPage>
          <EndPage>1543</EndPage>
          <MedlinePgn>1540-1543</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/09273948.2020.1754434</ELocationID>
        <Abstract>
          <AbstractText><b>Purpose</b>: To report the clinical profile of cataract and its surgical management in a scleritis cohort from India.<b>Methods</b>: We conducted a retrospective review of medical records of 39 eyes of 32 consecutive patients with scleritis who underwent cataract surgery in a tertiary eye care institute.<b>Results</b>: The mean age at presentation was 50.9 ± 11.1 years and 65.6% of the patients were female. Five patients (15.6%) were ≤ 40 years of age. Necrotizing scleritis (56.4%) was the most common subtype of scleritis in this cohort followed by diffuse anterior scleritis (28.2%), nodular scleritis (12.8%). The preferred incision for phacoemulsification was clear corneal in 30 eyes (77%). In the immediate post-operative period, four eyes (10.2%) developed severe corneal edema, one eye had descemet membrane detachment. Anterior chamber reaction was observed in 18 eyes (46.1%). Fifteen eyes (38.4%) developed raised intraocular pressure and two required surgical intervention after 3 months of cataract surgery. Early posterior capsular opacification was observed in 5 eyes (12.8%) and cystoid macular edema in 2 eyes (5.1%).<b>Conclusion</b>: In addition to providing a distinct pattern of cataract, index study showed that long-term control of scleral inflammation prior to the cataract surgery remains the primary requisite for the successful outcome.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Palkar</LastName>
            <ForeName>Amit</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Uvea Medical and Vision Research Foundations, Sankara Nethralaya, Chennai, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sudharshan</LastName>
            <ForeName>Sridharan</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Uvea Medical and Vision Research Foundations, Sankara Nethralaya, Chennai, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>George</LastName>
            <ForeName>Amala Elizabeth</ForeName>
            <Initials>AE</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Uvea Medical and Vision Research Foundations, Sankara Nethralaya, Chennai, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ganesh</LastName>
            <ForeName>Sudha K</ForeName>
            <Initials>SK</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Uvea Medical and Vision Research Foundations, Sankara Nethralaya, Chennai, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Biswas</LastName>
            <ForeName>Jyotirmay</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Uvea Medical and Vision Research Foundations, Sankara Nethralaya, Chennai, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dutta Majumder</LastName>
            <ForeName>Parthopratim</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Uvea Medical and Vision Research Foundations, Sankara Nethralaya, Chennai, India.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>05</Month>
          <Day>28</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Ocul Immunol Inflamm</MedlineTA>
        <NlmUniqueID>9312169</NlmUniqueID>
        <ISSNLinking>0927-3948</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007429" MajorTopicYN="N">Intraocular Pressure</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019654" MajorTopicYN="Y">Lens Implantation, Intraocular</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018918" MajorTopicYN="Y">Phacoemulsification</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015423" MajorTopicYN="N">Scleritis</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000072776" MajorTopicYN="N">Slit Lamp Microscopy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014065" MajorTopicYN="N">Tonometry, Ocular</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014792" MajorTopicYN="N">Visual Acuity</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Scleritis</Keyword>
        <Keyword MajorTopicYN="N">anterior nodular scleritis</Keyword>
        <Keyword MajorTopicYN="N">methotrexate</Keyword>
        <Keyword MajorTopicYN="N">necrotizing scleritis</Keyword>
        <Keyword MajorTopicYN="N">phacoemulsification</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>5</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>5</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32463347</ArticleId>
        <ArticleId IdType="doi">10.1080/09273948.2020.1754434</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
